We are live on
!
Find out more
CAM
Congress Asset Management Portfolio holdings
AUM
$16.3B
1-Year Est. Return
42.69%
This Fund
S&P 500
This Quarter
Est. Return
+9.74%
1 Year Est. Return
+42.69%
3 Year Est. Return
+133.81%
5 Year Est. Return
+171.24%
10 Year Est. Return
+841.07%
AUM
$11.5B
AUM Growth
+$780M
(+7.3%)
Cap. Flow
-$39.7M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
16.02%
Holding
391
New
23
Increased
185
Reduced
140
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Factset
FDS
|
+$106M |
| 2 |
Bruker
BRKR
|
+$98.1M |
| 3 |
HOLX
Hologic
HOLX
|
+$97.4M |
| 4 |
Martin Marietta Materials
MLM
|
+$69M |
| 5 |
Moody's
MCO
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Masco
MAS
|
+$103M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$89.3M |
| 3 |
Trimble
TRMB
|
+$81.1M |
| 4 |
Dover
DOV
|
+$79M |
| 5 |
Ciena
CIEN
|
+$60.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.8% |
| 2 | Healthcare | 17.55% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Industrials | 15.09% |
| 5 | Consumer Staples | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Oracle
ORCL
$404B
| $13.3M | 0.12% |
111,348
+108,358
| +3,624% | +$11.2M |
|
152
Ametek
AME
$55.5B
| $13.1M | 0.11% |
81,169
+877
| +1% | +$128K |
|
153
Amgen
AMGN
$204B
| $12.7M | 0.11% |
57,073
-212
| -0.4% | -$49.2K |
|
154
Colgate-Palmolive
CL
$72.3B
| $12.4M | 0.11% |
160,819
+1,370
| +0.9% | +$106K |
|
155
HEICO Corp
HEI
$50.3B
| $12.2M | 0.11% |
68,893
+1,383
| +2% | +$233K |
|
156
RPM International
RPM
$14.1B
| $12M | 0.1% |
133,809
+1,880
| +1% | +$155K |
|
157
United Parcel Service
UPS
$90.7B
| $11.7M | 0.1% |
65,160
+1,027
| +2% | +$182K |
|
158
DoubleVerify
DV
$1.77B
| $11.6M | 0.1% |
298,094
-2,304
| -0.8% | -$74.3K |
|
159
Align Technology
ALGN
$12.3B
| $11.5M | 0.1% |
32,516
-1,369
| -4% | -$436K |
|
160
Edwards Lifesciences
EW
$51.1B
| $11.1M | 0.1% |
118,066
+1,184
| +1% | +$103K |
|
161
Kulicke & Soffa
KLIC
$4.7B
| $10.7M | 0.09% |
180,452
+1,758
| +1% | +$90.7K |
|
162
UFP Technologies
UFPT
$2.05B
| $10.7M | 0.09% |
54,969
+19,386
| +54% | +$3M |
|
163
Allstate
ALL
$67.6B
| $10.6M | 0.09% |
97,189
+633
| +0.7% | +$71.8K |
|
164
Halozyme
HALO
$9.77B
| $10.4M | 0.09% |
+289,104
| New | +$9.86M |
|
165
Autodesk
ADSK
$49.7B
| $10.3M | 0.09% |
50,201
-1,201
| -2% | -$240K |
|
166
Range Resources
RRC
$9.41B
| $10.3M | 0.09% |
348,971
+8,683
| +3% | +$236K |
|
167
Terreno Realty
TRNO
$7.55B
| $10.1M | 0.09% |
167,532
+5,094
| +3% | +$311K |
|
168
Crown Castle
CCI
$33.9B
| $10M | 0.09% |
87,871
+1,119
| +1% | +$133K |
|
|
CCRN
169
DELISTED
Cross Country Healthcare
CCRN
| $9.98M | 0.09% |
355,534
+4,561
| +1% | +$113K |
|
170
Werner Enterprises
WERN
$2.2B
| $9.81M | 0.09% |
221,953
+27,502
| +14% | +$1.24M |
|
171
iShares Russell 1000 Growth ETF
IWF
$124B
| $9.72M | 0.08% |
141,236
-169,276
| -55% | -$10.8M |
|
|
172
Trimble
TRMB
$13.4B
| $9.54M | 0.08% |
180,248
-1,657,532
| -90% | -$81.1M |
|
173
Booking.com
BKNG
$149B
| $9.44M | 0.08% |
87,425
-3,400
| -4% | -$359K |
|
174
Workday
WDAY
$41B
| $9.33M | 0.08% |
+41,294
| New | +$8.27M |
|
175
Goldman Sachs
GS
$300B
| $9.32M | 0.08% |
28,902
-412
| -1% | -$135K |
|
Similar funds
UCFA
LCOV
CCMG
IG
EIP
CI
AIMCA
Congress Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Congress Asset Management held 391 positions worth $11.5B, up 7.3% from $10.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Congress Asset Management's Q2 2023 filing shows 23 new, 185 increased, 140 reduced and 18 closed positions. Its largest new stake was Factset: 263,630 shares worth $106M. The largest sale was Masco, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Congress Asset Management's largest Q2 2023 buy was Factset: 263,630 shares worth $106M.
- Congress Asset Management added most to Martin Marietta Materials in Q2 2023, an estimated $69M increase.
- Congress Asset Management's biggest Q2 2023 reduction was Neurocrine Biosciences, cutting an estimated $89.3M.
- Congress Asset Management fully exited Masco in Q2 2023, selling an estimated $103M.
- Congress Asset Management's ten largest holdings make up 16% of its $11.5B portfolio in Q2 2023.
- Congress Asset Management opened 23 new positions and closed 18 in Q2 2023.
- Congress Asset Management's portfolio value rose 7.3% quarter-over-quarter to $11.5B.
Based on Congress Asset Management's 13F filing for Q2 2023, filed 27 Jul 2023.